Monitoring of ototoxicity in young children receiving carboplatin for retinoblastoma.
Jehanne
Mathilde
M
Mercier
Ghislaine
G
Doz
François
F
D000970:Antineoplastic Agents / Q000009:adverse effects; D016190:Carboplatin / Q000009:adverse effects*; D002648:Child; D034381:Hearing Loss / Q000139:chemically induced*; D006320:Hearing Tests / Q000379:methods*; D006801:Humans; D012175:Retinoblastoma / Q000150:complications* / Q000188:drug therapy
D000970:Antineoplastic Agents; D016190:Carboplatin